Anti-CCL2 mAb treatment significantly suppressed development of arthritis in Il17g/gIl1rn−/− mice (Fig. 4a; Supplementary Fig. 5), suggesting an important role for CCL2 in pathogenesis. This evidence concerns the gene CCL2 and arthritic joint disease.